# Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior Uveitis

> **NCT02746991** · PHASE3 · COMPLETED · sponsor: **EyePoint Pharmaceuticals, Inc.** · enrollment: 153 (actual)

## Conditions studied

- Posterior Uveitis
- Intermediate Uveitis
- Panuveitis

## Interventions

- **DRUG:** Sham Injection
- **DRUG:** FAI Insert

## Key facts

- **NCT ID:** NCT02746991
- **Lead sponsor:** EyePoint Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06-02
- **Primary completion:** 2019-10-04
- **Final completion:** 2019-10-04
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2020-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02746991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02746991, "Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior Uveitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02746991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*